Vimarsana
Biggest News Aggregation in the World

Page 10 - Forefront Analytics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Forefront Analytics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Forefront Analytics Today - Breaking & Trending Today

Q1 2024 Earnings Estimate for Nkarta, Inc. Issued By HC Wainwright (NASDAQ:NKTX) - Vimarsana News

Q1 2024 Earnings Estimate for Nkarta, Inc. Issued By HC Wainwright (NASDAQ:NKTX)

Nkarta, Inc. (NASDAQ:NKTX – Free Report) – Investment analysts at HC Wainwright lifted their Q1 2024 earnings per share (EPS) estimates for shares of Nkarta in a report released on Monday, March 25th. HC Wainwright analyst E. Bodnar now forecasts that the company will earn ($0.46) per share for the quarter, up from their previous […]

Nkarta (NASDAQ:NKTX) Shares Gap Down to $11.09 - Vimarsana News

Nkarta (NASDAQ:NKTX) Shares Gap Down to $11.09

Nkarta, Inc. (NASDAQ:NKTX – Get Free Report) gapped down prior to trading on Thursday . The stock had previously closed at $11.09, but opened at $10.80. Nkarta shares last traded at $10.82, with a volume of 70,617 shares trading hands. Analyst Upgrades and Downgrades Several analysts recently weighed in on the stock. Mizuho reduced their […]

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives $18.42 Average PT from Brokerages - Vimarsana News

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives $18.42 Average PT from Brokerages

ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) has received an average recommendation of “Moderate Buy” from the seven ratings firms that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 1 year price […]

Nkarta (NASDAQ:NKTX) Price Target Increased to $16.00 by Analysts at Canaccord Genuity Group - Vimarsana News

Nkarta (NASDAQ:NKTX) Price Target Increased to $16.00 by Analysts at Canaccord Genuity Group

Nkarta (NASDAQ:NKTX – Get Free Report) had its price target increased by investment analysts at Canaccord Genuity Group from $15.00 to $16.00 in a report released on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective indicates a potential upside of 52.53% from the stock’s previous […]

Q1 2024 Earnings Forecast for Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Issued By William Blair - Vimarsana News

Q1 2024 Earnings Forecast for Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Issued By William Blair

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) – Equities research analysts at William Blair lifted their Q1 2024 EPS estimates for shares of Fusion Pharmaceuticals in a research report issued to clients and investors on Thursday, March 21st. William Blair analyst A. Hsieh now forecasts that the company will post earnings per share of ($0.39) […]